Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Operating Leases (2019 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Operating Leases for 7 consecutive years, with $147000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Operating Leases fell 67.48% to $147000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $147000.0, a 67.48% decrease, with the full-year FY2025 number at $147000.0, down 67.48% from a year prior.
  • Operating Leases was $147000.0 for Q4 2025 at Ekso Bionics Holdings, down from $237000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $1.4 million in Q3 2022 to a low of $97000.0 in Q1 2022.
  • A 5-year average of $560750.0 and a median of $412000.0 in 2021 define the central range for Operating Leases.
  • Peak YoY movement for Operating Leases: crashed 90.38% in 2021, then skyrocketed 929.9% in 2023.
  • Ekso Bionics Holdings' Operating Leases stood at $372000.0 in 2021, then soared by 192.2% to $1.1 million in 2022, then plummeted by 33.49% to $723000.0 in 2023, then tumbled by 37.48% to $452000.0 in 2024, then crashed by 67.48% to $147000.0 in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Operating Leases are $147000.0 (Q4 2025), $237000.0 (Q3 2025), and $358000.0 (Q2 2025).